IP Library Granted Patent US 12,417,822
Granted Patent B2
US 12,417,822 · App. 18/143,260 · Granted Sep 16, 2025

Management and coordination of data for digital therapeutics trials

Inventors: William Morse (New York, NY); Bailey Willis (New York, NY)
Assignee: Click Therapeutics, Inc.
G16H10/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,417,822
App. No.
18/143,260
Granted
Sep 16, 2025
Kind
B2
Abstract

Provided herein are systems and methods of managing access to data associated with trials for digital therapeutics on participants. A server can maintain a data storage for a plurality of phases associated with a trial for a digital therapeutic on participants. The data storage may include (i) a first portion of a plurality of datasets from the plurality of participants from one or more of the plurality of phases of the trial, and (ii) a second portion of the plurality of datasets from the digital therapeutics in at least one of the plurality of phases of the trial. The server can receive from a user device, a request identifying a phase of the plurality of phases for which the plurality of datasets is to be accessed. The server can select a corresponding portion of the plurality of datasets based on the request to provide the user device.

Claims (55)

1. A method of managing access to data associated with trials for digital therapeutics on participants, comprising:

receiving, by a server, from a user device, a request to define a plurality of parameters for at least one trial, the plurality of parameters identifying at least one of a digital therapeutic, a plurality of phases, or a respective endpoint for each of the plurality of phases;

establishing, by the server, a data lake comprising a data storage to store a plurality of datasets in at least one of a structured format or an unstructured format for the at least one trial in accordance with the plurality of parameters;

maintaining, by the server, for multiple digital therapeutics, the data lake for a plurality of phases associated with a trial for a digital therapeutic provided by a digital therapeutic application to a plurality of participants, the plurality of phases including (a) a pre-trial phase prior to commencing the trial for the digital therapeutic, (b) a trial phase during the trial, and (c) a post-trial phase subsequent to completion of the trial for the digital therapeutic, wherein the data lake maintains the data of the plurality of phases in a centralized manner, the data lake comprising:

(i) a plurality of datasets from the pre-trial phase,

(ii) a plurality of datasets from the trial phase, and

(iii) a plurality of datasets from the post-trial phase;

receiving, by the server, from the user device, an additional request associated with a participant or group of participants, an endpoint, and a phase of the plurality of phases for which the plurality of datasets is to be accessed;

selecting, by the server, a corresponding portion of the plurality of datasets based on the additional request, wherein the corresponding portion is selected by identifying linked data linked by an association between a plurality of trials; and

providing, by the server, to the user device, the corresponding portion of the plurality of datasets in the data lake.

2. The method of claim 1 , further comprising:

identifying, by the server, a plurality of trials associated with a corresponding plurality of conditions of the plurality of participants provided with the digital therapeutic; and

establishing, by the server, a plurality of data storages for the corresponding plurality of trials.

3. The method of claim 1 , further comprising:

receiving, by the server, from the user device, a second request to associate the data storage with a second data storage, the second data storage comprising a second plurality of datasets from a second trial separate from the trial associated with the data storage; and

linking, by the server, responsive to the second request, the second data storage with the data storage to provide the user device access to the data storage and the second data storage.

4. The method of claim 1 , further comprising identifying, by the server, from a plurality of access privileges, an access privilege for a user associated with the user device, and

wherein providing the corresponding portion further comprises providing the user device access to the portion of the plurality of datasets, responsive to the access privilege defining that the user is permitted to access the portion.

5. The method of claim 1 , wherein receiving the request further comprises:

receiving the request identifying a questionnaire to add to the phase of the plurality of phases; and

generating, by the server, at least one dataset identifying the questionnaire to add to at least one corresponding portion of the plurality of datasets.

6. The method of claim 1 , wherein maintaining the data storage further comprises removing, from the data storage, a first dataset in one portion of the plurality of datasets corresponding to a second dataset in another portion of the plurality of datasets.

7. The method of claim 1 , wherein receiving the request further comprises receiving the request identifying a participant of the plurality of participants for which the plurality of datasets is to be accessed;

wherein providing the access further comprises correlating, within the plurality of datasets on the data storage, one or more datasets associated with the participant identified in the request.

8. The method of claim 1 , wherein at least one of the plurality of datasets are generated using at least one of electronic data capture (EDC), identity verification, and informed consent.

9. The method of claim 1 , wherein at least one of the plurality of participants is administered with a pharmaceutical to address a condition, at least partially concurrently with use of the digital therapeutic.

10. A system for managing access to data associated with trials for digital therapeutics on participants, comprising:

at least one server having one or more processors coupled with memory, configured to:

receive, from a user device, a request to define a plurality of parameters for at least one trial, the plurality of parameters identifying at least one of a digital therapeutic, a plurality of phases, or a respective endpoint for each of the plurality of phases;

establish a data lake comprising a data storage to store a plurality of datasets in at least one of a structured format or an unstructured format for the at least one trial in accordance with the plurality of parameters;

maintain, for multiple digital therapeutics, the data lake for a plurality of phases associated with a trial for a digital therapeutic provided by a digital therapeutic application to a plurality of participants, the plurality of phases including (a) a pre-trial phase prior to commencing the trial for the digital therapeutic, (b) a trial phase during the trial, and (c) a post-trial phase subsequent to completion of the trial for the digital therapeutic, wherein the data lake maintains the data of the plurality of phases in a centralized manner, the data lake comprising:

(i) a plurality of datasets from the pre-trial phase,

(ii) a plurality of datasets from the trial phase, and

(iii) a plurality of datasets from the post-trial phase;

receive, from the user device, an additional request associated with a participant or group of participants, an endpoint, and a phase of the plurality of phases for which the plurality of datasets is to be accessed;

select a corresponding portion of the plurality of datasets based on the additional request, wherein the corresponding portion is selected by identifying linked data linked by an association between a plurality of trials; and

provide, to the user device, the corresponding portion of the plurality of datasets in the data lake.

11. The system of claim 10 , wherein the at least one server is further configured to:

identify a plurality of trials associated with a corresponding plurality of conditions of the plurality of participants provided with the digital therapeutic; and

establish a plurality of data storages for the corresponding plurality of trials.

12. The system of claim 10 , wherein the at least one server is further configured to:

receive, from the user device, a second request to associate the data storage with a second data storage, the second data storage comprising a second plurality of datasets from a second trial separate from the trial associated with the data storage; and

link, responsive to the second request, the second data storage with the data storage to provide the user device access to the data storage and the second data storage.

13. The system of claim 10 , wherein the at least one server is further configured to:

identify, from a plurality of access privileges, an access privilege for a user associated with the user device; and

wherein to provide the corresponding portion, the at least one server is configured to provide, to the user device associated with the user, access to the portion of the plurality of datasets, responsive to the access privilege defining that the user is permitted to access the portion.

14. The system of claim 10 , wherein the at least one server is further configured to:

receive the request identifying a questionnaire to add to the phase of the plurality of phases; and

generate at least one dataset identifying the questionnaire to add to at least one corresponding portion of the plurality of datasets.

15. The system of claim 10 , wherein the at least one server is further configured to remove, from the data storage, a first datasets in one portion of the plurality of datasets corresponding to a second dataset in another portion of the plurality of datasets.

16. The system of claim 10 , wherein the at least one server is further configured to:

receive the request identifying a participant of the plurality of participants for which the plurality of datasets is to be accessed;

correlate, within the plurality of datasets on the data storage, one or more datasets associated with the participant identified in the request.

17. The system of claim 10 , wherein at least one of the plurality of datasets are generated using at least one of electronic data capture (EDC), identity verification, and informed consent.

18. The system of claim 10 , wherein at least one of the plurality of participants is administered with a pharmaceutical to address a condition, at least partially concurrently with use of the digital therapeutic.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2024
From: WILLIS, BAILEY; MORSE, WILLIAM
To: CLICK THERAPEUTICS, INC.
Reel/Frame 067312/0458 →
Continuity (1)
Related Publication 20240371477A1 · Nov 7, 2024
References Cited (129)
US 10484845B2 · Khaleghi · 2019 [cited by examiner]
US 10653361B2 · DeBates · 2020 [cited by examiner]
US 10725652B2 · Bhavaraju · 2020 [cited by examiner]
US 10861595B2 · Satake · 2020 [cited by examiner]
US 10997243B1 · Paulus · 2021 [cited by examiner]
US 11020064B2 · Fountaine · 2021 [cited by examiner]
US 11036735B2 · Butani · 2021 [cited by examiner]
US 11061798B1 · Jain et al. · 2021 [cited by applicant]
US 11082487B1 · Jain · 2021 [cited by examiner]
US 11102304B1 · Jain et al. · 2021 [cited by applicant]
US 11222071B1 · Paulus · 2022 [cited by examiner]
US 11228875B2 · Khaleghi · 2022 [cited by examiner]
US 11233759B2 · Gao · 2022 [cited by examiner]
US D954730S · Kaminski · 2022 [cited by examiner]
US 11363999B2 · Fountaine · 2022 [cited by examiner]
US 11404062B1 · De · 2022 [cited by examiner]
US 11410655B1 · De · 2022 [cited by examiner]
US 11462307B2 · Satake · 2022 [cited by examiner]
US 11494438B2 · Paulus · 2022 [cited by examiner]
US 11500655B2 · Ziraknejad · 2022 [cited by examiner]
US 11521736B1 · Gastfriend · 2022 [cited by examiner]
US 11574743B1 · Soza · 2023 [cited by examiner]
US 11595498B2 · Jain · 2023 [cited by examiner]
US 11605038B1 · Jain · 2023 [cited by examiner]
US 11607182B2 · Fountaine · 2023 [cited by examiner]
US 11625294B2 · Bramble · 2023 [cited by examiner]
US 11651862B2 · Lure · 2023 [cited by examiner]
US 11664099B1 · Jain · 2023 [cited by examiner]
US 11682390B2 · Temkin · 2023 [cited by examiner]
US 11711422B1 · Jain · 2023 [cited by examiner]
US 11736564B1 · Jain · 2023 [cited by examiner]
US 11741238B2 · Rioux · 2023 [cited by examiner]
US 11749390B2 · Satake · 2023 [cited by examiner]
US 11756663B2 · Neumann · 2023 [cited by examiner]
US 11765249B2 · Erlingsson · 2023 [cited by examiner]
US 11770398B1 · Erlingsson · 2023 [cited by examiner]
US 11785104B2 · Erlingsson · 2023 [cited by examiner]
US 11790107B1 · Jain · 2023 [cited by examiner]
US 11792284B1 · Nanduri · 2023 [cited by examiner]
US 11797608B2 · Paulus · 2023 [cited by examiner]
US 11815994B2 · Bramble · 2023 [cited by examiner]
US 11818156B1 · Parikh · 2023 [cited by examiner]
US 11838365B1 · Jain · 2023 [cited by examiner]
US 11849000B2 · Williams · 2023 [cited by examiner]
US 11876875B2 · Banerjee · 2024 [cited by examiner]
US 11887736B1 · Norgeot · 2024 [cited by examiner]
US 11894984B2 · Erlingsson · 2024 [cited by examiner]
US 11895135B2 · Kapoor · 2024 [cited by examiner]
US 11909752B1 · Kapoor · 2024 [cited by examiner]
US 11916947B2 · Kapoor · 2024 [cited by examiner]
US 11922328B1 · Gdak · 2024 [cited by examiner]
US 11924152B2 · Gao · 2024 [cited by examiner]
US 11973784B1 · Erlingsson · 2024 [cited by examiner]
US 11979422B1 · Kapoor · 2024 [cited by examiner]
US 11991198B1 · Kapoor · 2024 [cited by examiner]
US 12002465B2 · De · 2024 [cited by examiner]
US 12007870B1 · Jain · 2024 [cited by examiner]
US 12008994B2 · De · 2024 [cited by examiner]
US 12021888B1 · Reed · 2024 [cited by examiner]
US 12034754B2 · O'Hearn · 2024 [cited by examiner]
US 12058160B1 · Erlingsson · 2024 [cited by examiner]
US 12073075B2 · Bhavaraju · 2024 [cited by examiner]
US 12079643B2 · Ziraknejad · 2024 [cited by examiner]
US 12086275B2 · Goswami · 2024 [cited by examiner]
US 12095794B1 · Karaje · 2024 [cited by examiner]
US 12095796B1 · Godefroid · 2024 [cited by examiner]
US 12095879B1 · Erlingsson · 2024 [cited by examiner]
US 20130191152A1 · Cremer et al. · 2013 [cited by applicant]
US 20150286802A1 · Kansara · 2015 [cited by applicant]
US 20180075219A1 · Klein · 2018 [cited by examiner]
US 20180173730A1 · Copenhaver · 2018 [cited by examiner]
US 20190005200A1 · Zimmerman · 2019 [cited by examiner]
US 20190149962A1 · Khaleghi · 2019 [cited by examiner]
US 20190220464A1 · Butani · 2019 [cited by examiner]
US 20200065122A1 · Ziraknejad · 2020 [cited by examiner]
US 20200065307A1 · Roy · 2020 [cited by examiner]
US 20200084595A1 · Khaleghi · 2020 [cited by examiner]
US 20200251111A1 · Temkin · 2020 [cited by examiner]
US 20210058490A1 · Jain · 2021 [cited by examiner]
US 20210386964A1 · Youngblood · 2021 [cited by examiner]
US 20210406310A1 · Paulus · 2021 [cited by examiner]
US 20220059228A1 · Chen · 2022 [cited by examiner]
US 20220114217A1 · Paulus · 2022 [cited by examiner]
US 20220114346A1 · Galitsky · 2022 [cited by examiner]
US 20220179979A1 · Goswami · 2022 [cited by examiner]
US 20220200869A1 · Erlingsson · 2022 [cited by examiner]
US 20220215101A1 · Rioux · 2022 [cited by examiner]
US 20220215948A1 · Bardot · 2022 [cited by examiner]
US 20220224707A1 · Kapoor · 2022 [cited by examiner]
US 20220232024A1 · Kapoor · 2022 [cited by examiner]
US 20220232025A1 · Kapoor · 2022 [cited by examiner]
US 20220247769A1 · Erlingsson · 2022 [cited by examiner]
US 20220279004A1 · Erlingsson · 2022 [cited by examiner]
US 20220293272A1 · Pang · 2022 [cited by examiner]
US 20220294816A1 · Martin · 2022 [cited by examiner]
US 20220303295A1 · Erlingsson · 2022 [cited by examiner]
US 20220311794A1 · Maya · 2022 [cited by examiner]
US 20220329616A1 · O'Hearn · 2022 [cited by examiner]
US 20220360600A1 · Reed · 2022 [cited by examiner]
US 20220367056A1 · Lure · 2022 [cited by examiner]
US 20220369077A1 · Khaleghi · 2022 [cited by examiner]
US 20220382620A1 · Bramble · 2022 [cited by examiner]
US 20220399112A1 · Bardot · 2022 [cited by examiner]
US 20220400129A1 · Kapoor · 2022 [cited by examiner]
US 20220400130A1 · Kapoor · 2022 [cited by examiner]
US 20230029927A1 · Ziraknejad · 2023 [cited by examiner]
US 20230032686A1 · Williams · 2023 [cited by examiner]
US 20230070255A1 · Paulus · 2023 [cited by examiner]
US 20230075355A1 · Twigg · 2023 [cited by examiner]
US 20230214289A1 · Bramble · 2023 [cited by examiner]
US 20230254330A1 · Singh · 2023 [cited by examiner]
US 20230275917A1 · Karmali · 2023 [cited by examiner]
US 20230319092A1 · Zeng · 2023 [cited by examiner]
US 20230328086A1 · Kapoor · 2023 [cited by examiner]
US 20230352169A1 · Whitmire · 2023 [cited by examiner]
US 20230386663A1 · Foody · 2023 [cited by examiner]
US 20230409636A1 · Paulus · 2023 [cited by examiner]
US 20230420093A1 · Pandipati · 2023 [cited by examiner]
US 20240080329A1 · Reed · 2024 [cited by examiner]
US 20240106846A1 · Kapoor · 2024 [cited by examiner]
US 20240143436A1 · Bramble · 2024 [cited by examiner]
US 20240153634A1 · Ghosh · 2024 [cited by examiner]
US 20240154884A1 · Jain · 2024 [cited by examiner]
US 20240194354A1 · Shandilya · 2024 [cited by examiner]
US 20240212846A1 · Yusuf · 2024 [cited by examiner]
US 20240257930A1 · Jenudi · 2024 [cited by examiner]
US 20240257972A1 · Getz · 2024 [cited by examiner]
US 20240338577A1 · Gdak · 2024 [cited by examiner]
International Search Report and Written Opinion for PCT Appl. No. PCT/US2023/20982, mailed Jul. 21, 2023. [cited by applicant]